407 related articles for article (PubMed ID: 19361459)
1. Role of serotonin in gastrointestinal motility and irritable bowel syndrome.
Sikander A; Rana SV; Prasad KK
Clin Chim Acta; 2009 May; 403(1-2):47-55. PubMed ID: 19361459
[TBL] [Abstract][Full Text] [Related]
2. Review article: serotonin receptors and transporters -- roles in normal and abnormal gastrointestinal motility.
Gershon MD
Aliment Pharmacol Ther; 2004 Nov; 20 Suppl 7():3-14. PubMed ID: 15521849
[TBL] [Abstract][Full Text] [Related]
3. [Role of serotonin in the pathophysiology of the irritable bowel syndrome].
Moskwa A; BoznaĆska P
Wiad Lek; 2007; 60(7-8):371-6. PubMed ID: 18175558
[TBL] [Abstract][Full Text] [Related]
4. Role of serotonin in the pathophysiology of the irritable bowel syndrome.
Crowell MD
Br J Pharmacol; 2004 Apr; 141(8):1285-93. PubMed ID: 15100164
[TBL] [Abstract][Full Text] [Related]
5. The serotonin signaling system: from basic understanding to drug development for functional GI disorders.
Gershon MD; Tack J
Gastroenterology; 2007 Jan; 132(1):397-414. PubMed ID: 17241888
[TBL] [Abstract][Full Text] [Related]
6. Serotonin receptors and their role in the pathophysiology and therapy of irritable bowel syndrome.
Stasi C; Bellini M; Bassotti G; Blandizzi C; Milani S
Tech Coloproctol; 2014 Jul; 18(7):613-21. PubMed ID: 24425100
[TBL] [Abstract][Full Text] [Related]
7. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.
Coates MD; Mahoney CR; Linden DR; Sampson JE; Chen J; Blaszyk H; Crowell MD; Sharkey KA; Gershon MD; Mawe GM; Moses PL
Gastroenterology; 2004 Jun; 126(7):1657-64. PubMed ID: 15188158
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease.
Spiller R
Neurogastroenterol Motil; 2007 Aug; 19 Suppl 2():25-31. PubMed ID: 17620085
[TBL] [Abstract][Full Text] [Related]
9. Nerves, reflexes, and the enteric nervous system: pathogenesis of the irritable bowel syndrome.
Gershon MD
J Clin Gastroenterol; 2005; 39(5 Suppl 3):S184-93. PubMed ID: 15798484
[TBL] [Abstract][Full Text] [Related]
10. Drugs acting on serotonin receptors for the treatment of functional GI disorders.
Tonini M; Pace F
Dig Dis; 2006; 24(1-2):59-69. PubMed ID: 16699264
[TBL] [Abstract][Full Text] [Related]
11. Rationale for using serotonergic agents to treat irritable bowel syndrome.
Baker DE
Am J Health Syst Pharm; 2005 Apr; 62(7):700-11; quiz 712-3. PubMed ID: 15790796
[TBL] [Abstract][Full Text] [Related]
12. 5-HT and the brain-gut axis: opportunities for pharmacologic intervention.
Crowell MD; Wessinger SB
Expert Opin Investig Drugs; 2007 Jun; 16(6):761-5. PubMed ID: 17501688
[TBL] [Abstract][Full Text] [Related]
13. 5-HT (serotonin) physiology and related drugs.
Gershon MD
Curr Opin Gastroenterol; 2000 Mar; 16(2):113-20. PubMed ID: 17024028
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome.
Jin DC; Cao HL; Xu MQ; Wang SN; Wang YM; Yan F; Wang BM
World J Gastroenterol; 2016 Sep; 22(36):8137-48. PubMed ID: 27688655
[TBL] [Abstract][Full Text] [Related]
15. The role of serotonin in irritable bowel syndrome: implications for management.
Garvin B; Wiley JW
Curr Gastroenterol Rep; 2008 Aug; 10(4):363-8. PubMed ID: 18627647
[TBL] [Abstract][Full Text] [Related]
16. Options for patients with irritable bowel syndrome: contrasting traditional and novel serotonergic therapies.
Johanson JF
Neurogastroenterol Motil; 2004 Dec; 16(6):701-11. PubMed ID: 15601419
[TBL] [Abstract][Full Text] [Related]
17. Review article: intestinal serotonin signalling in irritable bowel syndrome.
Mawe GM; Coates MD; Moses PL
Aliment Pharmacol Ther; 2006 Apr; 23(8):1067-76. PubMed ID: 16611266
[TBL] [Abstract][Full Text] [Related]
18. Enteric Microbiota-Mediated Serotonergic Signaling in Pathogenesis of Irritable Bowel Syndrome.
Mishima Y; Ishihara S
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638577
[TBL] [Abstract][Full Text] [Related]
19. Enterochromaffin cells and 5-HT signaling in the pathophysiology of disorders of gastrointestinal function.
Crowell MD; Shetzline MA; Moses PL; Mawe GM; Talley NJ
Curr Opin Investig Drugs; 2004 Jan; 5(1):55-60. PubMed ID: 14983974
[TBL] [Abstract][Full Text] [Related]
20. How Serotonin Level Fluctuation Affects the Effectiveness of Treatment in Irritable Bowel Syndrome.
Vahora IS; Tsouklidis N; Kumar R; Soni R; Khan S
Cureus; 2020 Aug; 12(8):e9871. PubMed ID: 32968548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]